← Eichor
Study identifier: NCT07172516 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Condition: Bipolar Disorder · Bipolar Depression · Bipolar I Disorder  ·  Sponsor: Xenon Pharmaceuticals Inc.

PhasePhase 3
Planned participants400
Who can joinAll sexes, 18 Years to 74 Years
Healthy volunteersNo

About this study

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult participants diagnosed with bipolar I or II disorder who are currently in a depressive episode (bipolar depression).

This description comes directly from the study's public registry record.

Talk to the study team

Xenon Medical Affairs  ·  1-604-484-3300  ·  XenonCares@xenon-pharma.com

Always discuss trial participation with your own doctor first.

Locations (28)

Noble Clinical ResearchTucson, Arizona, United StatesRecruiting
Woodland International Research GroupLittle Rock, Arkansas, United StatesRecruiting
Woodland Research NorthwestRogers, Arkansas, United StatesRecruiting
Clinical Innovations IncBellflower, California, United StatesRecruiting
ProScience Research GroupCulver City, California, United StatesRecruiting
ATP Clinical ResearchOrange, California, United StatesRecruiting
NRC Research InstituteOrange, California, United StatesRecruiting
Clinical Innovations IncRiverside, California, United StatesRecruiting
PharmaSouth Research, LLCCoral Gables, Florida, United StatesRecruiting
Clinical Neuroscience Solutions, Inc.Jacksonville, Florida, United StatesRecruiting
Central Miami Medical InstituteMiami, Florida, United StatesRecruiting
Clinical Neuroscience Solutions, IncOrlando, Florida, United StatesRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07172516